Sinocelltech Group Limited Class ASSE: 688520

Announcement on the Company's Voluntary Disclosure of Approval Notice for the Clinical Trial of Recombinant Respiratory Syncytial Virus Vaccine SCTV02 by the Company's Holding Subsidiary

· Issued by Sinocelltech Group Limited Class A via Shanghai Stock Exchange
Announcement on the Company's Voluntary Disclosure of Approval Notice for the Clinical Trial of Recombinant Respiratory Syncytial Virus Vaccine SCTV02 by the Company's Holding Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis